Today, Kezar Life Sciences announced topline results from the PRESIDIO study, evaluating the efficacy and safety of zetomipzomib in dermatomyositis and polymyositis. In this study, most patients experienced a clinically…
Continue Reading
Fun Fit Flex
In 2022, we will launch this interactive community awareness event in six local communities across the country where an estimated more than 40,000 dedicated participants will work to raise funds…
Continue Reading
Myositis Family Day
Celebrating Community – Click here to join
Continue Reading
Empowerment Clinic
Click here for more details
Continue Reading
Ask The Doc
Click here to register
Continue Reading